935
Views
94
CrossRef citations to date
0
Altmetric
Reviews

CD44: a validated target for improved delivery of cancer therapeutics

, PhD, , MD MS & , PhD
Pages 635-650 | Published online: 24 May 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Yu Hu, Yongrui Zhang, Jialin Gao, Xin Lian & Yuantao Wang. (2020) The clinicopathological and prognostic value of CD44 expression in bladder cancer: a study based on meta-analysis and TCGA data. Bioengineered 11:1, pages 572-581.
Read now
Zhengzou Fang, Xinyuan Li, Zeyan Xu, Fengyi Du, Wendi Wang, Ruihua Shi & Daqing Gao. (2019) Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery. International Journal of Nanomedicine 14, pages 5785-5797.
Read now
Srinath Palakurthi. (2015) Challenges in SN38 drug delivery: current success and future directions. Expert Opinion on Drug Delivery 12:12, pages 1911-1921.
Read now
Yoshiyuki Hattori, Haruka Yamasaku & Yoshie Maitani. (2013) Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection. Journal of Drug Targeting 21:7, pages 639-647.
Read now

Articles from other publishers (89)

Zhujun Xu. (2023) CRISPR/Cas9-mediated silencing of CD44: unveiling the role of hyaluronic acid-mediated interactions in cancer drug resistance. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Ravı KUMAR, Sunıta JHA & Akriti RAİ. (2023) Cd44 Targeted Plga Nano-Medicine For Cancer Chemotherapy- A Comprehensive Review. Journal of Immunology and Clinical Microbiology 8:3, pages 65-83.
Crossref
Amirhossein Izadpanah, Niloufar Mohammadkhani, Mina Masoudnia, Mahsa Ghasemzad, Arefeh Saeedian, Hamid Mehdizadeh, Mansour Poorebrahim & Marzieh Ebrahimi. (2023) Update on immune‐based therapy strategies targeting cancer stem cells. Cancer Medicine.
Crossref
Mahak Fatima, Afsana Sheikh, Mohammed A. S. Abourehab & Prashant Kesharwani. (2022) Advancements in Polymeric Nanocarriers to Mediate Targeted Therapy against Triple-Negative Breast Cancer. Pharmaceutics 14:11, pages 2432.
Crossref
Shujiang Wang, Shima Tavakoli, Rohith Pavan Parvathaneni, Ganesh N. Nawale, Oommen P. Oommen, Jöns Hilborn & Oommen P. Varghese. (2022) Dynamic covalent crosslinked hyaluronic acid hydrogels and nanomaterials for biomedical applications. Biomaterials Science 10:22, pages 6399-6412.
Crossref
Jianfeng Guo & Leaf Huang. (2022) Nanodelivery of cGAS-STING activators for tumor immunotherapy. Trends in Pharmacological Sciences 43:11, pages 957-972.
Crossref
Xiaoli Wu, Xiaoqing Meng, Tse-Shao Chang, Shuo Feng, Miki Lee, Sangeeta Jaiswal, Eun-Young K. Choi, Lam Tran, Hui Jiang & Thomas D. Wang. (2022) Multi-modal imaging for uptake of peptide ligand specific for CD44 by hepatocellular carcinoma. Photoacoustics 26, pages 100355.
Crossref
Jingyue Wang, Tong Zhou, Ying Liu, Shuangmin Chen & Zhenxiang Yu. (2022) Application of Nanoparticles in the Treatment of Lung Cancer With Emphasis on Receptors. Frontiers in Pharmacology 12.
Crossref
Franck Marquet & Gerrit Borchard. 2022. Polymeric Micelles for Drug Delivery. Polymeric Micelles for Drug Delivery 199 284 .
Xiaolu Guo, Naidi Yang, Wenhui Ji, Hang Zhang, Xiao Dong, Zhiqiang Zhou, Lin Li, Han‐Ming Shen, Shao Q. Yao & Wei Huang. (2021) Mito‐Bomb: Targeting Mitochondria for Cancer Therapy. Advanced Materials 33:43.
Crossref
Ting Liu, Xin Huang, Lingyun Zhao, Zhongqing Xiao, Zengbei Li, Yi Xin, Shanshan Yang, Di Guo, Wenfei Zhao, Yang Mi & Hongyun Li. (2021) Distinguishable Targeting of Non‐Small Cell Lung Cancer Using Hyaluronan Functionalized Platinum Nanoclusters and Their Inhibition Behaviors of Proliferation, Invasion, Migration. ChemistryOpen 10:9, pages 882-888.
Crossref
Chen Chen, Zhilun Zhao, Naixin Qian, Shixuan Wei, Fanghao Hu & Wei Min. (2021) Multiplexed live-cell profiling with Raman probes. Nature Communications 12:1.
Crossref
Xiuxiu Wang, Ru Cheng & Zhiyuan Zhong. (2021) Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel. Acta Biomaterialia 125, pages 280-289.
Crossref
Zhengzou Fang, Yanfei Shen & Daqing Gao. (2021) Stimulus-responsive nanocarriers for targeted drug delivery. New Journal of Chemistry 45:10, pages 4534-4544.
Crossref
Dongmiao Sang, Kai Wang, Xilin Sun, Ying Wang, Huiming Lin, Ran Jia & Fengyu Qu. (2021) NIR-Driven Intracellular Photocatalytic O 2 Evolution on Z-Scheme Ni 3 S 2 /Cu 1.8 S@HA for Hypoxic Tumor Therapy . ACS Applied Materials & Interfaces 13:8, pages 9604-9619.
Crossref
Jin Won Park, Kyung-Ho Jung, Jin Hee Lee, Seung Hwan Moon, Young Seok Cho & Kyung-Han Lee. (2021) 89Zr anti-CD44 immuno-PET monitors  CD44 expression on splenic myeloid cells and HT29 colon cancer cells. Scientific Reports 11:1.
Crossref
Kaihong Shi, Yu Wang, Xu Zhou, Hongqin Gui, Ningze Xu, Shengyue Wu, Cong He & Ziming Zhao. (2020) Tumor microenvironment targeting with dual stimuli-responsive nanoparticles based on small heat shock proteins for antitumor drug delivery. Acta Biomaterialia 114, pages 369-383.
Crossref
Xiaobin Zhang, Yi Wang, Guoqing Wei, Jingya Zhao, Guang Yang & Shaobing Zhou. (2020) Stepwise dual targeting and dual responsive polymer micelles for mitochondrion therapy. Journal of Controlled Release 322, pages 157-169.
Crossref
Jia Luo, ZhouXue Wu, Yun Lu, Kang Xiong, Qian Wen, Ling Zhao, BiQiong Wang, Yan Gui & ShaoZhi Fu. (2020) Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis. International Journal of Biological Macromolecules 152, pages 718-726.
Crossref
So Yun Lee, Moon Sung Kang, Woo Yeup Jeong, Dong-Wook Han & Ki Su Kim. (2020) Hyaluronic Acid-Based Theranostic Nanomedicines for Targeted Cancer Therapy. Cancers 12:4, pages 940.
Crossref
Nihad Al-Othman, Ala’ Alhendi, Manal Ihbaisha, Myassar Barahmeh, Moath Alqaraleh & Bayan Z. Al-Momany. (2020) Role of CD44 in breast cancer. Breast Disease 39:1, pages 1-13.
Crossref
Yingqi Xu, Dingxin Liu, Jie Hu, Peirong Ding & Meiwan Chen. (2020) Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment. International Journal of Pharmaceutics 573, pages 118637.
Crossref
Dhruv Kumar, Neelam Sharma-Walia, Sonia Kapoor & Simran Tandon. 2020. NanoBioMedicine. NanoBioMedicine 35 65 .
Wei Zheng, Cong Wang, Ruihong Ding, Yahong Huang, Yanyi Li & Yan Lu. (2019) Triptolide-loaded nanoparticles targeting breast cancer in vivo with reduced toxicity. International Journal of Pharmaceutics 572, pages 118721.
Crossref
Daniel Wai-Hung Ho, Yu-Man Tsui, Karen Man-Fong Sze, Lo-Kong Chan, Tan-To Cheung, Eva Lee, Pak-Chung Sham, Stephen Kwok-Wing Tsui, Terence Kin-Wah Lee & Irene Oi-Lin Ng. (2019) Single-cell transcriptomics reveals the landscape of intra-tumoral heterogeneity and stemness-related subpopulations in liver cancer. Cancer Letters 459, pages 176-185.
Crossref
Tongtong Miao, Xiufeng Ju, Qiuning Zhu, Yamei Wang, Qian Guo, Tao Sun, Chunzhu Lu & Liang Han. (2019) Nanoparticles Surmounting Blood–Brain Tumor Barrier Through Both Transcellular and Paracellular Pathways to Target Brain Metastases. Advanced Functional Materials 29:27.
Crossref
Qian Ren, Zhenguo Liang, Xin Jiang, Ping Gong, Lihua Zhou, Zhihong Sun, Jingjing Xiang, Zhen Xu, Xinghua Peng, Sanpeng Li, Wenjun Li, Lintao Cai & Jiaoning Tang. (2019) Enzyme and pH dual-responsive hyaluronic acid nanoparticles mediated combination of photodynamic therapy and chemotherapy. International Journal of Biological Macromolecules 130, pages 845-852.
Crossref
Shiva Mahmoudi, Marjan Ghorbani, Mehdi Sabzichi, Fatemeh Ramezani, Hamed Hamishehkar & Nasser Samadi. (2019) Targeted hyaluronic acid-based lipid nanoparticle for apigenin delivery to induce Nrf2-dependent apoptosis in lung cancer cells. Journal of Drug Delivery Science and Technology 49, pages 268-276.
Crossref
Stephan Marquardt, Manish Solanki, Alf Spitschak, Julio Vera & Brigitte M. Pützer. (2018) Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis. Seminars in Cancer Biology 53, pages 90-109.
Crossref
Shujun Dai, Zhimin Ye, Fangzheng Wang, Fengqin Yan, Lei Wang, Jun Fang, Zhun Wang & Zhenfu Fu. (2018) Doxorubicin‐loaded poly(ε‐caprolactone)‐Pluronic micelle for targeted therapy of esophageal cancer. Journal of Cellular Biochemistry 119:11, pages 9017-9027.
Crossref
Junji Ueda, Hiroshi Yoshida, Yasuhiro Mamada, Nobuhiko Taniai, Masato Yoshioka, Atsushi Hirakata, Youichi Kawano, Tetsuya Shimizu, Tomohiro Kanda, Hideyuki Takata & Eiji Uchida. (2018) Evaluation of the Impact of Preoperative Values of Hyaluronic Acid and Type IV Collagen on the Outcome of Patients with Hepatocellular Carcinoma After Hepatectomy. Journal of Nippon Medical School 85:4, pages 221-227.
Crossref
Ankit Saneja, Divya Arora, Robin Kumar, Ravindra Dhar Dubey, Amulya K. Panda & Prem N. Gupta. (2018) CD44 targeted PLGA nanomedicines for cancer chemotherapy. European Journal of Pharmaceutical Sciences 121, pages 47-58.
Crossref
Satish Agrawal, Monika Dwivedi, Hafsa Ahmad, Sangappa Basanna Chadchan, Abhishek Arya, Roshan Sikandar, Shweta Kaushik, Kalyan Mitra, Rajesh Kumar Jha & Anil Kumar Dwivedi. (2018) CD44 targeting hyaluronic acid coated lapatinib nanocrystals foster the efficacy against triple-negative breast cancer. Nanomedicine: Nanotechnology, Biology and Medicine 14:2, pages 327-337.
Crossref
Fengzheng Wu, Haixing Xu, Zhihua Zhu, Xin Li, Yahui Lü, Tian Ma, Xinjie Cai, Rui Li, Xiaobing Wang & Peihu Xu. (2017) Preparation and characterization of an intelligent multi-target tracking HA-RGD-CLB-QDs drug delivery system. Journal of Wuhan University of Technology-Mater. Sci. Ed. 32:6, pages 1493-1502.
Crossref
Yuelong Liang, Jiang Chen, Qingsong Yu, Tong Ji, Bin Zhang, Junjie Xu, Yi Dai, Yangyang Xie, Hui Lin, Xiao Liang & Xiujun Cai. (2017) Phosphorylated ERK is a potential prognostic biomarker for Sorafenib response in hepatocellular carcinoma. Cancer Medicine 6:12, pages 2787-2795.
Crossref
Khushwant S. Yadav, Rajiv Saxena & Govind Soni. 2017. Nanogels for Biomedical Applications. Nanogels for Biomedical Applications 143 160 .
Xiaoying Wang, Yamin Li, Quanshun Li, Caleb I. Neufeld, Dimitra Pouli, Shuo Sun, Liu Yang, Pu Deng, Ming Wang, Irene Georgakoudi, Shunqing Tang & Qiaobing Xu. (2017) Hyaluronic acid modification of RNase A and its intracellular delivery using lipid-like nanoparticles. Journal of Controlled Release 263, pages 39-45.
Crossref
Brigitte M. Pützer, Manish Solanki & Ottmar Herchenröder. (2017) Advances in cancer stem cell targeting: How to strike the evil at its root. Advanced Drug Delivery Reviews 120, pages 89-107.
Crossref
Lydia Ramzy, Maha Nasr, Abdelkader A. Metwally & Gehanne A.S. Awad. (2017) Cancer nanotheranostics: A review of the role of conjugated ligands for overexpressed receptors. European Journal of Pharmaceutical Sciences 104, pages 273-292.
Crossref
Jennifer M. Wickens, Hashem O. Alsaab, Prashant Kesharwani, Ketki Bhise, Mohd Cairul Iqbal Mohd Amin, Rakesh Kumar Tekade, Umesh Gupta & Arun K. Iyer. (2017) Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy. Drug Discovery Today 22:4, pages 665-680.
Crossref
Caifeng Deng, Quan Zhang, Yao Fu, Xun Sun, Tao Gong & Zhirong Zhang. (2017) Coadministration of Oligomeric Hyaluronic Acid-Modified Liposomes with Tumor-Penetrating Peptide-iRGD Enhances the Antitumor Efficacy of Doxorubicin against Melanoma. ACS Applied Materials & Interfaces 9:2, pages 1280-1292.
Crossref
M. Zhang, X. Zhao, Z. Fang, Y. Niu, J. Lou, Y. Wu, S. Zou, S. Xia, M. Sun & F. Du. (2017) Fabrication of HA/PEI-functionalized carbon dots for tumor targeting, intracellular imaging and gene delivery. RSC Advances 7:6, pages 3369-3375.
Crossref
Govind Soni & Khushwant S. Yadav. 2017. Modeling, Methodologies and Tools for Molecular and Nano-scale Communications. Modeling, Methodologies and Tools for Molecular and Nano-scale Communications 503 515 .
Kelly L. Mooney, Winward Choy, Sabrin Sidhu, Panayiotis Pelargos, Timothy T. Bui, Brittany Voth, Natalie Barnette & Isaac Yang. (2016) The role of CD44 in glioblastoma multiforme. Journal of Clinical Neuroscience 34, pages 1-5.
Crossref
Morteza Sarparast, Abolhassan Noori, Hoda Ilkhani, S. Zahra Bathaie, Maher F. El-Kady, Lisa J. Wang, Huong Pham, Kristofer L. Marsh, Richard B. Kaner & Mir F. Mousavi. (2016) Cadmium nanoclusters in a protein matrix: Synthesis, characterization, and application in targeted drug delivery and cellular imaging. Nano Research 9:11, pages 3229-3246.
Crossref
Kwang Yu, Meng Lin, Hyun-Ju Lee, Ki-Sik Tae, Bo-Sun Kang, Je Lee, Nam Lee, Young Jeong, Seung-Yun Han & Do Kim. (2016) Receptor-Meditated Endocytosis by Hyaluronic Acid@Superparamagnetic Nanovetor for Targeting of CD44-Overexpressing Tumor Cells. Nanomaterials 6:8, pages 149.
Crossref
Sofia Avnet & Margherita Cortini. (2016) Role of Pericellular Matrix in the Regulation of Cancer Stemness. Stem Cell Reviews and Reports 12:4, pages 464-475.
Crossref
Guangming Jin, Mingji Jin, Zhehu Jin, Zhonggao Gao & Xuezhe Yin. (2016) Docetaxel-loaded PEG-albumin nanoparticles with improved antitumor efficiency against non-small cell lung cancer. Oncology Reports.
Crossref
Carlo Baggio, Elisa Barile, Gianluigi Di Sorbo, Thomas J. Kipps & Maurizio Pellecchia. (2016) The Cell Surface Receptor CD44: NMR-Based Characterization of Putative Ligands. ChemMedChem 11:10, pages 1097-1106.
Crossref
Fatemeh Ravar, Ebrahim Saadat, Mehdi Gholami, Pouya Dehghankelishadi, Mehdi Mahdavi, Samira Azami & Farid A. Dorkoosh. (2016) Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. Journal of Controlled Release 229, pages 10-22.
Crossref
Jihe Zhao. (2016) Cancer stem cells and chemoresistance: The smartest survives the raid. Pharmacology & Therapeutics 160, pages 145-158.
Crossref
Jae-Young Lee, Suk-Jae Chung, Hyun-Jong Cho & Dae-Duk Kim. (2016) Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging. Biomaterials 85, pages 218-231.
Crossref
M. Swierczewska, H.S. Han, K. Kim, J.H. Park & S. Lee. (2016) Polysaccharide-based nanoparticles for theranostic nanomedicine. Advanced Drug Delivery Reviews 99, pages 70-84.
Crossref
Vivek Badwaik, Linjia Liu, Dinara Gunasekera, Aditya Kulkarni & David H. Thompson. (2016) Mechanistic Insight into Receptor-Mediated Delivery of Cationic-β-Cyclodextrin:Hyaluronic Acid-Adamantamethamidyl Host:Guest pDNA Nanoparticles to CD44 + Cells . Molecular Pharmaceutics 13:3, pages 1176-1184.
Crossref
Nazila Kamaly, Basit Yameen, Jun Wu & Omid C. Farokhzad. (2016) Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. Chemical Reviews 116:4, pages 2602-2663.
Crossref
W.G. Jiang, A.J. Sanders, M. Katoh, H. Ungefroren, F. Gieseler, M. Prince, S.K. Thompson, M. Zollo, D. Spano, P. Dhawan, D. Sliva, P.R. Subbarayan, M. Sarkar, K. Honoki, H. Fujii, A.G. Georgakilas, A. Amedei, E. Niccolai, A. Amin, S.S. Ashraf, L. Ye, W.G. Helferich, X. Yang, C.S. Boosani, G. Guha, M.R. Ciriolo, K. Aquilano, S. Chen, A.S. Azmi, W.N. Keith, A. Bilsland, D. Bhakta, D. Halicka, S. Nowsheen, F. Pantano & D. Santini. (2015) Tissue invasion and metastasis: Molecular, biological and clinical perspectives. Seminars in Cancer Biology 35, pages S244-S275.
Crossref
Yumin Oh, Magdalena Swierczewska, Tae Hyung Kim, Sung Mook Lim, Ha Na Eom, Jae Hyung Park, Dong Hee Na, Kwangmeyung Kim, Kang Choon Lee, Martin G. Pomper & Seulki Lee. (2015) Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors. Journal of Controlled Release 220, pages 671-681.
Crossref
Li ZHANG, Jian-Ping ZHOU & Jing YAO. (2015) Improved anti-tumor activity and safety profile of a paclitaxel-loaded glycyrrhetinic acid-graft-hyaluronic acid conjugate as a synergistically targeted drug delivery system. Chinese Journal of Natural Medicines 13:12, pages 915-924.
Crossref
Maurizio Viale, Marta Rossi, Eleonora Russo, Michele Cilli, Anna Aprile, Aldo Profumo, Pierluigi Santi, Carla Fenoglio, Sergio Cafaggi & Mattia Rocco. (2015) Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model. Investigational New Drugs 33:6, pages 1151-1161.
Crossref
GUANGMING JIN, MINGJI JIN, XUEZHE YIN, ZHEHU JIN, LIQING CHEN & ZHONGGAO GAO. (2015) A comparative study on the effect of docetaxel-albumin nanoparticles and docetaxel-loaded PEG-albumin nanoparticles against non-small cell lung cancer. International Journal of Oncology 47:5, pages 1945-1953.
Crossref
Alessandro Canella, Hector Cordero Nieves, Douglas W. Sborov, Luciano Cascione, Hanna S. Radomska, Emily Smith, Andrew Stiff, Jessica Consiglio, Enrico Caserta, Lara Rizzotto, Nicola Zanesi, Volinia Stefano, Balveen Kaur, Xiaokui Mo, John C. Byrd, Yvonne A. Efebera, Craig C. Hofmeister & Flavia Pichiorri. (2015) HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide. Oncotarget 6:31, pages 31134-31150.
Crossref
Yoon Yeo & Bieong-Kil Kim. (2015) Drug Carriers: Not an Innocent Delivery Man. The AAPS Journal 17:5, pages 1096-1104.
Crossref
Pål Kristian Selbo, Monica Bostad, Cathrine Elisabeth Olsen, Victoria Tudor Edwards, Anders Høgset, Anette Weyergang & Kristian Berg. (2015) Photochemical internalisation, a minimally invasive strategy for light-controlled endosomal escape of cancer stem cell-targeting therapeutics. Photochemical & Photobiological Sciences 14:8, pages 1433-1450.
Crossref
Qin Pan, Qiao Li, Shuang Liu, Ning Ning, Xiaolian Zhang, Yingxin Xu, Alfred E. Chang & Max S. Wicha. (2015) Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches. Stem Cells 33:7, pages 2085-2092.
Crossref
Xiaoqian Yang, Arun K. lyer, Amit Singh, Edwin Choy, Francis J. Hornicek, Mansoor M. Amiji & Zhenfeng Duan. (2015) MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer. Scientific Reports 5:1.
Crossref
V. Orian-Rousseau & H. Ponta. (2014) Perspectives of CD44 targeting therapies. Archives of Toxicology 89:1, pages 3-14.
Crossref
Antonio Di Meglio, Pier Vitale Nuzzo, Francesco Ricci, Bruno Spina & Francesco Boccardo. (2014) Incidental advanced-stage Hodgkin lymphoma diagnosed at the time of radical prostatectomy for prostatic cancer: a case report and review of literature. BMC Cancer 14:1.
Crossref
Tuan Hiep Tran, Ju Yeon Choi, Thiruganesh Ramasamy, Duy Hieu Truong, Chien Ngoc Nguyen, Han-Gon Choi, Chul Soon Yong & Jong Oh Kim. (2014) Hyaluronic acid-coated solid lipid nanoparticles for targeted delivery of vorinostat to CD44 overexpressing cancer cells. Carbohydrate Polymers 114, pages 407-415.
Crossref
Hao Liu, Ke Li, Liang Xu & Daocheng Wu. (2014) Bilayered near-infrared fluorescent nanoparticles based on low molecular weight PEI for tumor-targeted in vivo imaging. Journal of Nanoparticle Research 16:12.
Crossref
Amelie Pajip Megaptche, Ulrike Erb, Markus Wolfgang Büchler & Margot Zöller. (2014) CD44v10, osteopontin and lymphoma growth retardation by a CD44v10‐specific antibody. Immunology & Cell Biology 92:8, pages 709-720.
Crossref
Monica Bostad, Marianne Kausberg, Anette Weyergang, Cathrine Elisabeth Olsen, Kristian Berg, Anders Høgset & Pål Kristian Selbo. (2014) Light-Triggered, Efficient Cytosolic Release of IM7-Saporin Targeting the Putative Cancer Stem Cell Marker CD44 by Photochemical Internalization. Molecular Pharmaceutics 11:8, pages 2764-2776.
Crossref
Yunqi Zhao, Ti Zhang, Shaofeng Duan, Neal M. Davies & M. Laird Forrest. (2014) CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 10:6, pages 1221-1230.
Crossref
Euan Murray, Lenka Hernychová, Michaela Scigelova, Jenny Ho, Marta Nekulova, John Robert O’Neill, Rudolf Nenutil, Karel Vesely, Sinclair R. Dundas, Catharine Dhaliwal, Hannah Henderson, Richard L. Hayward, Donald M. Salter, Bořivoj Vojtěšek & Ted R. Hupp. (2014) Quantitative Proteomic Profiling of Pleomorphic Human Sarcoma Identifies CLIC1 as a Dominant Pro-Oncogenic Receptor Expressed in Diverse Sarcoma Types. Journal of Proteome Research 13:5, pages 2543-2559.
Crossref
E. Markoutsa, K. Papadia, A. D. Giannou, M. Spella, A. Cagnotto, M. Salmona, G. T. Stathopoulos & S. G. Antimisiaris. (2013) Mono and Dually Decorated Nanoliposomes for Brain Targeting, In Vitro and In Vivo Studies. Pharmaceutical Research 31:5, pages 1275-1289.
Crossref
Richard d'Arcy & Nicola Tirelli. (2014) Fishing for fire: strategies for biological targeting and criteria for material design in anti‐inflammatory therapies. Polymers for Advanced Technologies 25:5, pages 478-498.
Crossref
Yu-Sheng Liu, Chien-Chih Chiu, Hsuan-Ying Chen, Su-Hwei Chen & Li-Fang Wang. (2014) Preparation of Chondroitin Sulfate- g -poly(ε-caprolactone) Copolymers as a CD44-Targeted Vehicle for Enhanced Intracellular Uptake . Molecular Pharmaceutics 11:4, pages 1164-1175.
Crossref
Silvia Arpicco, Paola Milla, Barbara Stella & Franco Dosio. (2014) Hyaluronic Acid Conjugates as Vectors for the Active Targeting of Drugs, Genes and Nanocomposites in Cancer Treatment. Molecules 19:3, pages 3193-3230.
Crossref
Cord Naujokat. (2014) Monoclonal antibodies against human cancer stem cells. Immunotherapy 6:3, pages 290-308.
Crossref
Guoqiang Chang, Hongju Zhang, Jian Wang, Yujuan Zhang, Hua Xu, Chijuan Wang, Hairui Zhang, Li Ma, Qinghua Li & Tianxiang Pang. (2013) CD44 targets Wnt/β-catenin pathway to mediate the proliferation of K562 cells. Cancer Cell International 13:1.
Crossref
Abdulaziz Almalik, Roberto Donno, Christopher J. Cadman, Francesco Cellesi, Philip J. Day & Nicola Tirelli. (2013) Hyaluronic acid-coated chitosan nanoparticles: Molecular weight-dependent effects on morphology and hyaluronic acid presentation. Journal of Controlled Release 172:3, pages 1142-1150.
Crossref
Wenjun Miao, Gayong Shim, Choong Mo Kang, Soondong Lee, Yearn Seong Choe, Han-Gon Choi & Yu-Kyoung Oh. (2013) Cholesteryl hyaluronic acid-coated, reduced graphene oxide nanosheets for anti-cancer drug delivery. Biomaterials 34:37, pages 9638-9647.
Crossref
Abdulaziz Almalik, Philip J. Day & Nicola Tirelli. (2013) HA ‐ C oated Chitosan Nanoparticles for CD 44‐ M ediated Nucleic Acid Delivery . Macromolecular Bioscience 13:12, pages 1671-1680.
Crossref
Rajendar K. Mittapalli, Xinli Liu, Chris E. Adkins, Mohamed I. Nounou, Kaci A. Bohn, Tori B. Terrell, Hussaini S. Qhattal, Werner J. Geldenhuys, Diane Palmieri, Patricia S. Steeg, Quentin R. Smith & Paul R. Lockman. (2013) Paclitaxel–Hyaluronic NanoConjugates Prolong Overall Survival in a Preclinical Brain Metastases of Breast Cancer Model. Molecular Cancer Therapeutics 12:11, pages 2389-2399.
Crossref
Lizette Ghazi‐Visser, Jon D. Laman, Sabine Nagel, Marjan Meurs, Debby Riel, Alexandar Tzankov, Stephan Frank, Heiner Adams, Kerstin Wolk, Luigi Terracciano, Marie‐José Melief, Robert Sabat & Ursula Günthert. (2013) CD44 variant isoforms control experimental autoimmune encephalomyelitis by affecting the lifespan of the pathogenic T cells. The FASEB Journal 27:9, pages 3683-3701.
Crossref
Abdulaziz Almalik, Shima Karimi, Sihem Ouasti, Roberto Donno, Christine Wandrey, Philip J. Day & Nicola Tirelli. (2013) Hyaluronic acid (HA) presentation as a tool to modulate and control the receptor-mediated uptake of HA-coated nanoparticles. Biomaterials 34:21, pages 5369-5380.
Crossref
Wenli Zheng, Dingshen Liu, Xiangshan Fan, Linda Powers, Maitrayee Goswami, Ying Hu, Pei Lin, L. Jeffrey Medeiros & Sa A. Wang. (2013) Potential therapeutic biomarkers in plasma cell myeloma: A flow cytometry study. Cytometry Part B: Clinical Cytometry 84B:4, pages 222-228.
Crossref
Silvia Arpicco, Giuseppe De Rosa & Elias Fattal. (2013) Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells. Journal of Drug Delivery 2013, pages 1-8.
Crossref
Anita Yakkundi, Lynn McCallum, Anthony O’Kane, Hayder Dyer, Jenny Worthington, Hayley D. McKeen, Lana McClements, Christopher Elliott, Helen O. McCarthy, David G. Hirst & Tracy Robson. (2013) The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway. PLoS ONE 8:2, pages e55075.
Crossref
Qinglei Zhan, Chunmei Wang & Saiming Ngai. (2013) Ovarian Cancer Stem Cells: A New Target for Cancer Therapy. BioMed Research International 2013, pages 1-10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.